These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20699217)

  • 1. Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.
    Rouet V; Bogorad RL; Kayser C; Kessal K; Genestie C; Bardier A; Grattan DR; Kelder B; Kopchick JJ; Kelly PA; Goffin V
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15199-204. PubMed ID: 20699217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
    Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
    Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin-induced prostate tumorigenesis links sustained Stat5 signaling with the amplification of basal/stem cells and emergence of putative luminal progenitors.
    Sackmann-Sala L; Chiche A; Mosquera-Garrote N; Boutillon F; Cordier C; Pourmir I; Pascual-Mathey L; Kessal K; Pigat N; Camparo P; Goffin V
    Am J Pathol; 2014 Nov; 184(11):3105-19. PubMed ID: 25193592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and murine prostate basal/stem cells are not direct targets of prolactin.
    Sackmann-Sala L; Angelergues A; Boutillon F; d'Acremont B; Maidenberg M; Oudard S; Goffin V
    Gen Comp Endocrinol; 2015 Sep; 220():133-42. PubMed ID: 25888939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin-induced prostate tumorigenesis.
    Sackmann-Sala L; Goffin V
    Adv Exp Med Biol; 2015; 846():221-42. PubMed ID: 25472541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
    Xu X; Kreye E; Kuo CB; Walker AM
    Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of pure prolactin receptor antagonists.
    Bernichtein S; Kayser C; Dillner K; Moulin S; Kopchick JJ; Martial JA; Norstedt G; Isaksson O; Kelly PA; Goffin V
    J Biol Chem; 2003 Sep; 278(38):35988-99. PubMed ID: 12824168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice.
    Boutillon F; Pigat N; Sala LS; Reyes-Gomez E; Moriggl R; Guidotti JE; Goffin V
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31269779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
    Llovera M; Pichard C; Bernichtein S; Jeay S; Touraine P; Kelly PA; Goffin V
    Oncogene; 2000 Sep; 19(41):4695-705. PubMed ID: 11032019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
    Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
    Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.
    Thomas LN; Merrimen J; Bell DG; Rendon R; Goffin V; Too CK
    Prostate; 2014 May; 74(7):732-42. PubMed ID: 24615730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
    Goffin V
    Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.
    Memarzadeh S; Cai H; Janzen DM; Xin L; Lukacs R; Riedinger M; Zong Y; DeGendt K; Verhoeven G; Huang J; Witte ON
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7962-7. PubMed ID: 21518863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
    Li H; Ahonen TJ; Alanen K; Xie J; LeBaron MJ; Pretlow TG; Ealley EL; Zhang Y; Nurmi M; Singh B; Martikainen PM; Nevalainen MT
    Cancer Res; 2004 Jul; 64(14):4774-82. PubMed ID: 15256446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A major prolactin-binding complex on human milk fat globule membranes contains cyclophilins A and B: the complex is not the prolactin receptor.
    Lorenson MY; Ueda EK; Chen KE; Walker AM
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E585-94. PubMed ID: 22205628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.
    Kindblom J; Dillner K; Sahlin L; Robertson F; Ormandy C; Törnell J; Wennbo H
    Endocrinology; 2003 Jun; 144(6):2269-78. PubMed ID: 12746285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors.
    Untergasser G; Rumpold H; Hermann M; Dirnhofer S; Jilg G; Berger P
    Exp Gerontol; 1999 Apr; 34(2):275-87. PubMed ID: 10363793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.
    Mapes J; Anandan L; Li Q; Neff A; Clevenger CV; Bagchi IC; Bagchi MK
    J Biol Chem; 2018 Feb; 293(8):2850-2864. PubMed ID: 29321207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
    Langenheim JF; Tan D; Walker AM; Chen WY
    Mol Endocrinol; 2006 Mar; 20(3):661-74. PubMed ID: 16269515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro.
    Ahonen TJ; Härkönen PL; Rui H; Nevalainen MT
    Endocrinology; 2002 Jan; 143(1):228-38. PubMed ID: 11751614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.